ERBB2 and breast cancer: In vitro, cancer cell-intrinsic LOX-PP expression inhibited the proliferation and invasion of prostate, pancreatic, and mammary carcinoma cells, and suppressed signaling pathways downstream of oncogenic Her2/Neu (breast cancer) and Ras (prostate and pancreatic cancer) [153,154,155].